Potential use of an asparaginase-dextran conjugate in acute lymphoblastic leukaemia
- 1 November 1983
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 35 (11), 762-765
- https://doi.org/10.1111/j.2042-7158.1983.tb02891.x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Improvement in the persistence of microbial asparaginase and glutaminase in the circulation of the rat by chemical modificationsBiochimica et Biophysica Acta (BBA) - General Subjects, 1981
- ACCUMULATION OF [3H]-OUABAIN IN FUNCTIONALLY DIFFERENT CANINE CARDIAC TISSUES: DIFFERENTIAL Rb+ UPTAKEBritish Journal of Pharmacology, 1981
- Increased Circulatory Lifetime of the Antileukemic Enzyme L-AsparaginaseJournal of Pharmacy and Pharmacology, 1979
- The effect of chemical modification of L-asparaginase on its persistence in circulating blood of animalsBiochemical Pharmacology, 1979
- Toxicity of glutaminase in patients with advanced lymphoblastic leukaemiaLeukemia Research, 1978
- Bacterial glutaminase in treatment of acute leukaemia.BMJ, 1976
- Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coliCancer, 1972
- l-Asparaginase from Erwinia carotovoraPublished by Elsevier ,1972
- In vitro Cytocidal Effect of L-Glutaminase on Leukaemic LymphocytesNature, 1971
- Colorimetric Method for Determination of Sugars and Related SubstancesAnalytical Chemistry, 1956